Article,

A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study

, , , , , , , and .
Dermatologic Surgery, 47 (1): 42--46 (2021)

Meta data

Tags

Users

  • @clausius

Comments and Reviews